Abdominal Neoplasms - 350 Studies Found
| Completed |
: Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer :
|
| Active, not recruiting |
: Phase 2 AMG 386 in Comb. Paclitaxel for Subjects With Advanced Recurrent Epithelial Ovarian or Primary Peritoneal Cancer :
|
| Completed |
: Abraxane Plus Carboplatin for Recurrent Platinum-Sensitive Ovarian Cancer :
|
| Completed |
: Mifepristone in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer :
|
| Completed |
: Intraperitoneal Hyperthermic Perfusion With Oxaliplatin in Treating Patients With Stage IV Peritoneal Cancer Due to Appendix Cancer or Colorectal Cancer :
|
| Terminated |
: Vandetanib to Treat Women With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer :
|
| Completed |
: Testing Drug Sensitivity of Ovarian, Fallopian and Primary Peritoneal Adenocarcinomas :
|
| Completed |
: A Phase I Study of Ovarian Cancer Peptides Plus GM-CSF and Adjuvant With Ovarian, Tubal or Peritoneal Cancer : Epithelial Ovarian, Tubal or Peritoneal Cancer : 2007-02-19 :
|
| Completed |
: Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer :
|
| Completed |
: VEGF Trap and Docetaxel in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer :
|